10.13.26 -- Building Smarter Paths To Commercial Success

Explore how global manufacturing networks, strategic investments, and collaborative tech transfer approaches are helping drug developers accelerate programs, secure capacity, and navigate evolving regulatory and supply chain challenges.

Successful commercialization takes more than development alone. Explore the manufacturing, quality, and supply chain strategies that support speed, compliance, and supply.

Recombinant Factor C testing offers a pharmacopeia-recognized, animal-free alternative to LAL with fewer interference risks, but regulatory hesitation slows adoption across the industry.

We integrate lipid synthesis, purification, and GMP manufacturing from grams to multi-ton scale, offering custom ionizable, PEG, and phospholipids for LNP programs.

End-to-end nanomedicine support accelerates development through integrated formulation, scaling, and manufacturing from research to commercialization.

Integrated development and manufacturing services support biologic drug substances from early cell line work through commercial production, offering technologies and global capacity.

An integrated development and manufacturing approach that cuts handoffs, manages risk, and accelerates timelines by uniting formulation, analytics, production, and packaging.

A biologics analytics leader showcases development, testing, and characterization capabilities, emphasizing quality, regulatory compliance, and support from discovery to commercialization.

Downstream purification is becoming more complex as new modalities enter development. Learn how advanced analytics and chromatography strategies can support process development.

Multiparticulates enable tailored drug release with improved flexibility, dose accuracy, and patient convenience, leveraging technologies like Diffucaps® for customized profiles including immediate, delayed, extended, and pulsatile delivery.

Move drug development into the modern era with a CRO that offers assay development and validation, bioanalytical testing, sample prep, and more. Explore why choosing Dash Bio is a smart decision for accelerating bioanalysis.

Learn how we balance discovery and development as an asset scales, and how a model keeps the original process scientists attached to a molecule from first kilos through NDA.